INHBE and pulmonary arterial hypertension: We tested these endothelial cells using transcriptomics and found that they have the characteristic changes observed in PAH patients, including specific abnormalities in PAH treatment pathways, i.e. nitric oxide, endothelin, prostacyclin and BMP/activin pathways.